Tonix Pharmaceuticals Holding Corp banner

Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP

Watchlist Manager
Tonix Pharmaceuticals Holding Corp Logo
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Watchlist
Price: 12.88 USD -6.33% Market Closed
Market Cap: $164.7m

Wall Street
Price Targets

TNXP Price Targets Summary
Tonix Pharmaceuticals Holding Corp

Wall Street analysts forecast TNXP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNXP is 67.66 USD with a low forecast of 64.64 USD and a high forecast of 73.5 USD.

Lowest
Price Target
64.64 USD
402% Upside
Average
Price Target
67.66 USD
425% Upside
Highest
Price Target
73.5 USD
471% Upside
Tonix Pharmaceuticals Holding Corp Competitors:
Price Targets
CALM
Cal-Maine Foods Inc
16% Upside
LGI
Lgi Ltd
35% Upside
ANY
ANY Biztonsagi Nyomda Nyrt
-1% Downside
AMAL
Amalgamated Bank
13% Upside
INBK
First Internet Bancorp
32% Upside
SPWH
Sportsmans Warehouse Holdings Inc
156% Upside

Revenue
Forecast

N/A
Past Growth
112% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
112% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate of Tonix Pharmaceuticals Holding Corp's revenue for the next 3 years is 112%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNXP's stock price target?
Price Target
67.66 USD

According to Wall Street analysts, the average 1-year price target for TNXP is 67.66 USD with a low forecast of 64.64 USD and a high forecast of 73.5 USD.

What is Tonix Pharmaceuticals Holding Corp's Revenue forecast?
Projected CAGR
112%

The compound annual growth rate of Tonix Pharmaceuticals Holding Corp's revenue for the next 3 years is 112%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett